In 2023 Lilly published results of its phase 2 trial for orforglipron, a once-daily oral drug which achieved up to 14.7% mean weight reduction at 36 weeks, and Pfizer has completed phase 2 trial for its oral drug danuglipron and is now optimising the formulation
For ulnar (pinky side) issues including TFCC: Inject in the depression between the ulnar styloid and the fifth metacarpal base
The emotional burden of severe psoriasis, historically termed the heartbreak of psoriasis, can increase the risk of psychological disorders (Parisi 2013
Its powerful antioxidant properties help reduce the signs of ageing, such as wrinkles and skin sagging
Guilherme Rizzoto, Ghent University, Belgium
In addition to these skin lightening protocols, Dr